Eli Lilly and Company - SWOT Analysis - New Research Report on Companies and Markets

Aug. 15, 2008 - PRLog -- Eli Lilly and Company - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Eli Lilly and Company (Lilly) is a global, research-based pharmaceutical company, headquartered in the US. The company has approximately 41,350 employees worldwide and its products are marketed in 143 countries. The company recorded revenues of $15,691 million during the fiscal year ended December 2006, an increase of 7.1% over 2005. The increase was primarily attributable to strong sales performance of Cymbalta, Forteo, Byetta, Zyprexa, and Alimta. The operating profit of the company was $3,180.2 million during fiscal year 2006, an increase of 32.3% over 2005. The net profit was $2,662.7 million in fiscal year 2006, an increase of 34.5% over 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information availablehttp://www.companiesandmarkets.com/Summary-Company-Profil...